LACTOSE (INDIA) LTD. (LACTOSE) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of LACTOSE (INDIA) LTD. stock ₹105.95, price ₹88.95, upside +19.1%, quality 40 out of 100. Rating: undervalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
LACTOSE (INDIA) LTD.
LACTOSE · BSEOnly slightly cheap (16% below fair value), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 19, 2026.
How to read this chart
60‑month range ₹31.50 – ₹235.75 · fair‑value band ₹79.40 – ₹132.44 · the ₹88.95 price screens below the ₹105.95 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 19, 2026.
Every Wednesday you see whether LACTOSE (INDIA) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India. The company is involved in the production of drugs, medicines, chemicals, foods, etc.
Show moreShow less
It offers lactose monohydrate; dry granulated, film, and lacquer coated tablets; and pharmaceutical products in solid dose forms.
In addition, the company provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic.
It also exports its products. The company was incorporated in 1991 and is headquartered in Mumbai, India.
Stock analysis
LACTOSE (INDIA) LTD. (LACTOSE) currently trades at ₹88.95, while our model-based Fair Value estimate is ₹105.95, implying the stock looks roughly 16% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹174.79 per share, and 8 of the 14 models we run sit above the ₹88.95 price.
Bear case: the Asset-Based group reads lowest at ₹34.43, and 6 of the 14 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹79.40 (bear) to ₹132.44 (bull), the price of ₹88.95 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 40/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
LACTOSE (INDIA) LTD. reported revenue of ₹1.6B in FY2025 versus ₹459M in FY2021, a compound +37.3%/yr. Reported net income was ₹60.6M in FY2025, compounding +25.4%/yr from FY2021.
Key figures
Market cap ₹1.2B (≈ $12.4M) Micro · P/E ratio 16.4 · P/S ratio 0.68 · EPS (TTM) ₹5.41 · Net margin 4.1% · Return on equity 9.8% · Return on assets (EBIT) 8.9% (5-year average) · Operating margin 9.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 41 out of 100 (medium confidence).
What moves the price
The share trades about 31% below its 52-week high and 14% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −26% fair-value upside, at 19%, LACTOSE screens cheaper than that median.
Fair Value models
All 14 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch LACTOSE, get fair value alerts →
Compare LACTOSE (INDIA) LTD. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 611 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Fair value gap by industry
- Return on assets by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $79.11 | $113.53 | +44% | vs LACTOSE |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.00 | ¥51.70 | +10% | vs LACTOSE |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,884.90 | ₹1,982.92 | +5% | vs LACTOSE |
| Haleon plc HLN | $9.07 | $8.47 | −7% | vs LACTOSE |
| Merck KGaA MRK | €146.45 | €108.83 | −26% | vs LACTOSE |
| Galderma Group GALD | CHF 182.85 | CHF 112.84 | −38% | vs LACTOSE |
| Teva Pharmaceutical Industries Limited TEVA | $39.23 | $20.74 | −47% | vs LACTOSE |
| Takeda Pharmaceutical Company TAK | $21.77 | $11.26 | −48% | vs LACTOSE |
| Sandoz Group SDZ | CHF 80.50 | CHF 40.87 | −49% | vs LACTOSE |
| Divi's Laboratories Limited DIVISLAB | ₹11,180.50 | ₹1,566.89 | −86% | vs LACTOSE |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is LACTOSE (INDIA) LTD. (LACTOSE) overvalued or undervalued?
What is the fair value of LACTOSE?
What is the quality score of LACTOSE?
What is the price target for LACTOSE (INDIA) LTD. (LACTOSE)?
What is the LACTOSE (INDIA) LTD. stock forecast for 2026?
What is the revenue of LACTOSE (INDIA) LTD. (LACTOSE)?
What is the intrinsic value of LACTOSE (INDIA) LTD. (LACTOSE)?
Is LACTOSE (INDIA) LTD. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of LACTOSE?
How much is LACTOSE (INDIA) LTD. worth?
What do the bullish and bearish scenarios say about LACTOSE?
What is the P/E ratio of LACTOSE?
How solid is the balance sheet of LACTOSE (INDIA) LTD. (LACTOSE)?
How far is LACTOSE from its 52-week high?
Which stocks are comparable to LACTOSE (INDIA) LTD.?
Is LACTOSE (INDIA) LTD. stock attractive at the current price?
How is the fair value of LACTOSE calculated?
Is it still worth investing in stocks now?
What is the share price of LACTOSE (INDIA) LTD. (LACTOSE)?
What should I pay attention to with LACTOSE (INDIA) LTD. right now?
Key figures of LACTOSE (INDIA) LTD.
How large is the market capitalisation of LACTOSE (INDIA) LTD. (LACTOSE)?
What is the P/S ratio of LACTOSE (INDIA) LTD. (LACTOSE)?
What are the earnings per share of LACTOSE (INDIA) LTD. (LACTOSE)?
What is the net margin of LACTOSE (INDIA) LTD. (LACTOSE)?
What is the return on equity of LACTOSE (INDIA) LTD. (LACTOSE)?
What is the EBIT return on assets of LACTOSE (INDIA) LTD. (LACTOSE)?
What is the operating margin of LACTOSE (INDIA) LTD. (LACTOSE)?
How fast is revenue growing at LACTOSE (INDIA) LTD. (LACTOSE)?
How fast are earnings growing at LACTOSE (INDIA) LTD. (LACTOSE)?
How much free cash flow does LACTOSE (INDIA) LTD. (LACTOSE) generate?
How much net debt does LACTOSE (INDIA) LTD. (LACTOSE) carry?
Watch LACTOSE (INDIA) LTD. in the live analysis
One click puts LACTOSE (INDIA) LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.